Résumé : The invention concerns the use for treating periodontitis of a fluid pharmaceutical composition for controlled release of at least one active substance comprising: a) a therapeutically efficient amount of at least an active substance; b) 3 to 55 wt. % of phospholipid; c) 16 to 72 wt. % of one or...